These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 21713359
1. [Insulin-like growth factor receptor I signaling in a breast cancer cell line]. Mejía W, Castro C, Umaña A, de Castro C, Riveros T, Sánchez-Gómez M. Biomedica; 2010; 30(4):551-8. PubMed ID: 21713359 [Abstract] [Full Text] [Related]
2. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Bartucci M, Morelli C, Mauro L, Andò S, Surmacz E. Cancer Res; 2001 Sep 15; 61(18):6747-54. PubMed ID: 11559546 [Abstract] [Full Text] [Related]
3. Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathway. del Rincón SV, Rousseau C, Samanta R, Miller WH. Oncogene; 2003 May 29; 22(22):3353-60. PubMed ID: 12776186 [Abstract] [Full Text] [Related]
6. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I. Sachdev D, Li SL, Hartell JS, Fujita-Yamaguchi Y, Miller JS, Yee D. Cancer Res; 2003 Feb 01; 63(3):627-35. PubMed ID: 12566306 [Abstract] [Full Text] [Related]
13. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity. Salatino M, Schillaci R, Proietti CJ, Carnevale R, Frahm I, Molinolo AA, Iribarren A, Charreau EH, Elizalde PV. Oncogene; 2004 Jul 01; 23(30):5161-74. PubMed ID: 15122317 [Abstract] [Full Text] [Related]
14. c-myb stimulates cell growth by regulation of insulin-like growth factor (IGF) and IGF-binding protein-3 in K562 leukemia cells. Kim MS, Kim SY, Arunachalam S, Hwang PH, Yi HK, Nam SY, Lee DY. Biochem Biophys Res Commun; 2009 Jul 17; 385(1):38-43. PubMed ID: 19427836 [Abstract] [Full Text] [Related]
16. RAV12 accelerates the desensitization of Akt/PKB pathway of insulin-like growth factor I receptor signaling in COLO205. Li JC, Li R. Cancer Res; 2007 Sep 15; 67(18):8856-64. PubMed ID: 17875727 [Abstract] [Full Text] [Related]
18. In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417. Haluska P, Carboni JM, Loegering DA, Lee FY, Wittman M, Saulnier MG, Frennesson DB, Kalli KR, Conover CA, Attar RM, Kaufmann SH, Gottardis M, Erlichman C. Cancer Res; 2006 Jan 01; 66(1):362-71. PubMed ID: 16397250 [Abstract] [Full Text] [Related]
19. Activation of insulin-like growth factor I receptor signaling pathway is critical for mouse plasma cell tumor growth. Li W, Hyun T, Heller M, Yam A, Flechner L, Pierce JH, Rudikoff S. Cancer Res; 2000 Jul 15; 60(14):3909-15. PubMed ID: 10919668 [Abstract] [Full Text] [Related]
20. The expression and role of hybrid insulin/insulin-like growth factor receptor type 1 in endometrial carcinoma cells. Zhang G, Li X, Zhang L, Zhao L, Jiang J, Wang J, Wei L. Cancer Genet Cytogenet; 2010 Jul 15; 200(2):140-8. PubMed ID: 20620597 [Abstract] [Full Text] [Related] Page: [Next] [New Search]